Hannah Shapiro

Dr. Hannah Shapiro

Boston Children's Hospital
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2021 in Children
Verified
Journal Article
Open access
PDF file
HSHannah Shapiro
Hannah Shapiro
ALAlyssa Lebel
Alyssa Lebel
Migraine headache is a common cause of pain and disability in children and adolescents and is a major contributor to frequently missed school days and limitations in activities. Of children and adolescents with migraine headache, approximately one-third have migraine with aura (MA). MA is often considered to be similar to migraine without aura (MO), and thus, many studies do not stratify patients based on the presence of aura. Because of this, treatment recommendations are often analogous between MA and MO, with a few notable exceptions. The purpose of this review is to highlight the current evidence demonstrating the unique pathophysiology, clinical characteristics, differential diagnosis, co-morbidities, and treatment recommendations and responses for pediatric MA.

1 February 2022 in Pediatric Neurology
Verified
Journal Article
Open access
HSHannah Shapiro
Hannah Shapiro
JSJenifer Sant
Jenifer Sant
AMAnna Minster
Anna Minster
RARichard C. Antonelli
Richard C. Antonelli
Care for pediatric patients with headache often occurs in high-cost settings such as emergency departments (EDs) and inpatient settings. Outpatient infusion centers have the potential to reduce care costs for pediatric headache management. In this quality improvement study, we describe our experience in creating the capacity to support an integrated outpatient pediatric headache infusion care model through an infusion center. We compare costs of receiving headache treatment in this model with those in the emergency and inpatient settings. Because dihydroergotamine (DHE) is a costly infusion, encounters at which DHE was administered were analyzed separately. We track the number of ED visits and inpatient admissions for headache using run charts. As a balancing measure, we compare treatment efficacy between the infusion care model and the inpatient setting. The mean percentage increase in cost of receiving headache treatment in the inpatient setting with DHE was 61% (confidence interval [CI]: 30-99%), and that without DHE was 582% (CI: 299-1068%) compared with receiving equivalent treatments in the infusion center. The mean percentage increase in cost of receiving headache treatment in the ED was 30% (CI: -15 to 100%) compared with equivalent treatment in the infusion center. After the intervention, ED visits and inpatient admissions for headache decreased. The mean change in head pain was similar across care settings. Our findings demonstrate that developing an integrated ambulatory care model with infusion capacity for refractory pediatric headache is feasible, and our early outcomes suggest this may have a favorable impact on the overall value of care for this population.

11 September 2023 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Open access
HSHannah Shapiro
Hannah Shapiro
ELElizabeth Loder
Elizabeth Loder
DSDaniel J. Shapiro
Daniel J. Shapiro
Objective: We aimed to compare the prescribing patterns of preventive medications between pediatric and adult neurologists for young adults with migraine.Background: Although preventive medications are effective for adults with migraine, studies in children have failed to demonstrate similar efficacy. As a result, lifestyle modifications and non‐pharmacological interventions are often emphasized in children. It is not known whether young adults are prescribed preventive medications at different rates according to whether they are cared for by an adult or pediatric neurologist.Methods: We performed a multicenter retrospective cohort analysis of patients with migraine aged 18–25 years who were seen by a pediatric or adult neurologist at Mass General Brigham Hospital between 2017 and 2021. The primary outcome was whether the patient received a prescription for any preventive medication during the study period.Results: Among the 767 included patients, 290 (37.8%) were seen by a pediatric neurologist. Preventive medications were prescribed for 131/290 (45.2%; 95% confidence interval [CI]: 39.5%, 51.0%) patients seen by a pediatric neurologist and 206/477 (43.2%; 95% CI: 39.0%, 47.7%) patients seen by an adult neurologist (p = 0.591). In the mixed effects logistic regression model, clinician specialty was not associated with preventive medication use (adjusted odds ratio [AOR] 1.20, 95% CI: 0.62, 2.31). Female sex (AOR 1.69, 95% CI: 1.07, 2.66) and number of visits during the study period (AOR 1.64, 95% CI: 1.49, 1.80) were associated with receiving preventive medication.Conclusion: Approximately two fifths of young adults with migraine were prescribed preventive medications, and this proportion did not differ according to clinician specialty. Although these findings suggest that pediatric and adult neurologists provide comparable care, both specialties may be underusing preventive medications in this patient population.

26 September 2025 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Open access
HSHannah Shapiro
Hannah Shapiro
AGAmy A. Gelfand
Amy A. Gelfand
DSDaniel J. Shapiro
Daniel J. Shapiro
HEHolly Elser
Holly Elser
CCChen Chen
Chen Chen
JCJoan A. Casey
Joan A. Casey
Objective: The purpose of this study was to determine whether short‐term exposure to wildfire smoke is associated with emergency department visits for headache in children and adolescents. Background: Wildfires are becoming increasingly common and are associated with numerous adverse health outcomes. However, we currently do not know how wildfire smoke exposure affects children and adolescents with primary headache disorders. Headache disorders in youth are a major contributor to frequently missed school days and youth with headache disorders have high medical care utilization and total healthcare costs. Therefore, understanding factors that may contribute to headache exacerbations and potential increases in healthcare utilization is of particular interest. Methods: This was a time‐stratified case‐crossover study linking daily health data from the California Department of Health Care Access and Information to daily ZIP code‐level wildfire PM 2.5 concentrations between 2006 and 2019. We included all visits for headache to emergency departments in California among youth 5–19 years old during the study period. The primary exposure was the ZIP code‐level daily wildfire‐specific PM 2.5 concentration, modeled as a continuous and binary (wildfire‐specific PM 2.5 ≥15 μg/m 3 ) variable. The primary outcome was an emergency department visit for headache. We identified relevant encounters according to the International Classification of Diseases, 9th/10th revision codes assigned in the first diagnostic position. To capture a potential delayed impact, we estimated odds ratios for the association for days 0 to 6 between the exposure and outcome. Results: We identified 206,230 unique emergency department encounters for primary headache disorders. Most visits were in female patients (61.4%) 15–19 years old (58.5%) who identified as Hispanic (48.8%) and lived in a very low‐opportunity (37.7%) or low‐opportunity (21.6%) neighborhood. The adjusted odds of an emergency department visit incrementally decreased per unit increase in wildfire‐specific PM 2.5 concentrations from days 0 to 6 after wildfire smoke exposure (same‐day adjusted odds ratio [aOR], 1.00; 95% confidence interval [CI], 0.998–1.001; day +6 aOR, 0.995; 95% CI, 0.993–0.997). Using a binary exposure, the adjusted odds of an emergency department visit incrementally decreased from days 0 to 6 after a wildfire smoke day (same day aOR, 0.99; 95% CI, 0.92–1.08; day +6 aOR, 0.84; 95% CI, 0.78–0.92). Conclusion: Children are less likely to seek care in the emergency department for primary headache in the days following exposure to wildfire smoke, suggesting that healthcare utilization changes during wildfires. Clinicians should ensure youth with headache disorders who experience worsening symptoms associated with air pollution are equipped with strategies to manage their headache disorder at home during days with wildfire smoke, including effective at‐home acute headache medications.

24 January 2026 in Headache: The Journal of Head and Face Pain
Verified
Journal Article
Closed access
HSHannah Shapiro
Hannah Shapiro